A High-Throughput Platform for COVID-19 Serodiagnosis, Vaccine Evaluation, and Drug Discovery

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3R01AI134907-03S2

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $699,894
  • Funder

    National Institutes of Health (NIH)
  • Principle Investigator

    Pending
  • Research Location

    United States of America, Americas
  • Lead Research Institution

    The University of Texas Medical Branch at Galveston
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    Gender

  • Study Subject

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

In response to the current COVID-19 pandemic, it is of paramount importance to rapidly diagnoseinfections and to develop countermeasures. This project aims to build a high-throughput platformfor rapid COVID-19 serodiagnosis, vaccine evaluation, and therapeutics development.